Home > Insider Trading > Filing (0001181431-12-047856)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
820096	Perrigo Co	PRGO	Pharmaceutical Preparations (2834)	382799573

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1267878	W Todd Kingma	C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010	Executive Vp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-08-27	11,514	$110.66	25,057	No	4	M	Direct
Common Stock	Disposition	2012-08-27	4,698	$110.66	20,359	No	4	F	Direct
Common Stock	Disposition	2012-08-27	6,936	$110.66	27,295	No	4	M	Direct
Common Stock	Disposition	2012-08-27	2,830	$110.66	24,465	No	4	F	Direct
Common Stock	Disposition	2012-08-28	1,760	$0.00	2,386	No	5	G	Indirect	By Trust
Common Stock	Disposition	2012-08-28	5,000	$110.66	19,465	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	5	G	Indirect	By Trust
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2012-08-27	11,514	$0.00	11,514	$0.00
Common Stock	Restricted Stock Units	Disposition	2012-08-27	6,936	$0.00	6,936	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2012-08-27	2012-08-27	No	4	M	Direct
0	2012-08-27	2012-08-27	No	4	M	Direct

Footnotes

Vesting of Performance-based Restricted Stock Units granted on August 25, 2009.
Vesting of Restricted Stock Units granted on August 25, 2009.
By Trust, of which the reporting person is the Trustee.
This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on March 7, 2012. This 10b5-1 sales plan will expire on the close of business December 31, 2012.
The price in column 4 is a weighted average. The prices actually received ranged from $110.14 to $111.02. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.